The Vanguard Group 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | Calithera Biosciences, Inc. CALA | The Vanguard Group | 143,080 3.820% | -40,655 (-22.13%) | Filing |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Calithera Biosciences, Inc. CALA | The Vanguard Group | 183,735 5.210% | 183,735 (New Position) | Filing |